To further investigate the mechanism by which KIF9 promotes macroautophagy in AD, we transfected the KIF9 plasmid into 2EB2 cells for 4 h, followed by co‐treatment with the macroautophagy inhibitor CQ (50 μM) for an additional 24 h. This evidence concerns the gene KIF9 and Alzheimer disease.